Bionic nanoparticles based on alkaliophilic granulocyte membranes, preparation method thereof and application thereof in preparation of drugs for treating allergic diseases
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- THE SECOND HOSPITAL AFFILIATED TO WENZHOU MEDICAL COLLEGE
- Filing Date
- 2026-06-05
- Publication Date
- 2026-07-07
AI Technical Summary
Existing treatments for allergic diseases cannot effectively block IgE-mediated allergic cascade reactions, and existing drugs such as omalizumab have short half-lives, making it difficult to completely control asthma.
Biomimetic nanoparticles based on basophil membranes were used to reduce IgE concentration and alleviate the allergic cascade reaction through the high affinity binding of the FcεRI protein to IgE. These biomimetic nanoparticles were made by encapsulating the cell membrane of a rat basophilic leukemia cell line with a PLGA support and prepared using gradient centrifugation and water bath sonication techniques.
It significantly reduces IgE concentration, blocks the allergy cascade, and relieves allergy symptoms. It has a highly effective allergy-blocking effect and good biocompatibility.
Smart Images

Figure CN122342736A_ABST